Author Archive: AZBio
That’s a switch! Synthetic circuits regulate gene expression
During the first flickering of life on earth, ribonucleic acid (RNA) occupied center stage. Since its shadowy beginnings, RNA has become a basic constituent of all living cells, faithfully transcribing DNA messages contained in genes and translating these into proteins.
Now, Alex Green and his group at ASU’s Biodesign Institute and scientists from the Wyss Institute for Biologically Inspired Engineering and Northwestern University, along with a group of international colleagues are carrying RNA’s startling capacities a step further.Continue reading
AZBio Honors Ten Arizona Legislators as Trailblazers

Arizona Commerce Authority Announces Semifinalists in the Fall Arizona 2019 Innovation Challenge
PHOENIX, AZ (October 30, 2019) — The Arizona Commerce Authority announced today that semifinalists have been selected in the Fall 2019 Arizona Innovation Challenge (AIC). The competition is among the largest in the country and designed to advance innovation and technology commercialization opportunities in Arizona by helping early-stage ventures scale.
UA Cancer Center Receives $8.6M Grant to Lead One of Three NCI Clinical Trials Networks
The University of Arizona Cancer Center has received an $8.6 million grant from the National Cancer Institute for the UA Cancer Prevention Clinical Trials Network, one of only three such networks funded by the NCI.Continue reading
Axolotl Obtains CMS Billing Codes for Products
Centers for Medicare and Medicaid Services Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue RegenerationContinue reading
CATS Tonometer Prism™ Now Available for Order in the U.S.
TUCSON, Arizona, October 23, 2019 – The CATS Tonometer Reusable Prism™ is now available for order through a variety of key distributors in the United States. A breakthrough in intraocular pressure (IOP) accuracy, the CATS Tonometer Prism™ establishes a new standard in reliable Goldmann IOP measurement.Continue reading
Systems Oncology Receives Investment from The Pritzker Organization
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests advised by TPO have invested in the first closing of SO’s Series B round. The funding will be used to invest in both discovery research and pre-clinical development to evolve SO’s rapidly expanding pipeline of innovative cancer therapeutics.